Of these mediators, only MyD88 (2.2 vs. 0.6, p = 0.002), and IL‐6 (4.2 vs. 1.0, p = 0.007, Figure 2b,d) were increased in the RV following 8 h CIS‐reperfusion. This evidence concerns the gene MYD88 and in situ carcinoma.